AI assistant
Sending…
TherapeuticsMD, Inc. — Director's Dealing 2019
Aug 31, 2019
35134_dirs_2019-08-30_9a1c9584-f813-4619-bdbc-a8b17a8147c5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2019-08-28
Reporting Person: Finizio Robert G (Director, CEO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-08-28 | Non-Qualified Stock Option (right to buy) | $2.73 | A | 1 | Acquired | 2029-08-28 | Common Stock (1) | Direct |
More from TherapeuticsMD, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Major Shareholding Notification
2026
Apr 7
Annual Report
2026
Apr 1
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 30
Regulatory Filings
2026
Jan 20
Director's Dealing
2025
Dec 29
Regulatory Filings
2025
Dec 16